Immunovant, Inc. (IMVT)
25.40
+0.05
(+0.20%)
USD |
NASDAQ |
Dec 31, 14:39
Immunovant EPS Diluted (Quarterly): -0.7285 for Sept. 30, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Revvity, Inc. | 0.4066 |
| Viridian Therapeutics, Inc. | -0.423 |
| Perspective Therapeutics, Inc. | -0.3495 |
| Electromed, Inc. | 0.246 |
| Xtant Medical Holdings, Inc. | 0.0087 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -126.50M |
| Total Expenses (Quarterly) | 126.50M |
| Enterprise Value | 3.921B |
| Earnings Yield | -11.14% |
| Normalized Earnings Yield | -11.14 |